TransEnterix, Inc. (TRXC): Price and Financial Metrics


TransEnterix, Inc. (TRXC)

Today's Latest Price: $0.36 USD

0.02 (-5.83%)

Updated Oct 30 8:00pm

Add TRXC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

TRXC Stock Summary

  • With a year-over-year growth in debt of -90.47%, Transenterix Inc's debt growth rate surpasses just 1.68% of about US stocks.
  • Revenue growth over the past 12 months for Transenterix Inc comes in at -78.87%, a number that bests just 1.71% of the US stocks we're tracking.
  • In terms of volatility of its share price, TRXC is more volatile than 94.88% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Transenterix Inc are COHR, FTK, FSLR, RENN, and JAZZ.
  • TRXC's SEC filings can be seen here. And to visit Transenterix Inc's official web site, go to www.transenterix.com.

TRXC Stock Price Chart Interactive Chart >

Price chart for TRXC

TRXC Price/Volume Stats

Current price $0.36 52-week high $4.42
Prev. close $0.38 52-week low $0.28
Day low $0.36 Volume 766,340
Day high $0.38 Avg. volume 3,413,738
50-day MA $0.38 Dividend yield N/A
200-day MA $0.56 Market Cap 35.96M

TransEnterix, Inc. (TRXC) Company Bio


TransEnterix, Inc. focuses on the development and commercialization of a robotic assisted surgical system in the United States and internationally. The company is based in Morrisville, North Carolina.


TRXC Latest News Stream


Event/Time News Detail
Loading, please wait...

TRXC Latest Social Stream


Loading social stream, please wait...

View Full TRXC Social Stream

Latest TRXC News From Around the Web

Below are the latest news stories about Transenterix Inc that investors may wish to consider to help them evaluate TRXC as an investment opportunity.

Neurosurgery Surgical Navigation System Market Estimated To Flourish By 2027 with Prominent Key Players: Intuitive Surgical, Stryker, Restoration Robotics, Medtech S.A, Mazor Robotics, THINK Surgical, Medrobotics, TransEnterix

Neurosurgery Surgical navigation system offers both optical and EM tracking capabilities, integration with external devices like microscopes and ultrasound, a broad array of instrument offerings, and core software applications for neurosurgery and spine procedures including Biopsy. Report Consultant has introduced

OpenPR | September 30, 2020

TransEnterix Announces Establishment of Japanese Training Center for Senhance Surgical System

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it established the first training center for the Senhance® Surgical System in the Asia-Pacific region in Japan at the Saitama Medical University International Medical Center in the Greater Tokyo Area. “The Asia-Pacific region has been a major contributor of

Business Wire | September 14, 2020

TransEnterix to Present at the H. C. Wainwright 22nd Annual Global Investment Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC) announced today that Anthony Fernando, President and Chief Executive Officer and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at the H. C. Wainwright 22nd Annual Global Investment Conference. The presentation is scheduled to take place virtually at 3:00 PM Eastern, Tuesday, September 15, 2020. A live audio webcast of the conference presentation will be available online

Business Wire | September 8, 2020

TransEnterix Announces New Employment Inducement Grant

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that in connection with the appointment of Shameze Rampertab as the Company’s Executive Vice President and Chief Financial Officer effective August 24, 2020, the Compensation Committee of the Company’s Board of Directors granted the following inducement grants

Business Wire | August 25, 2020

TransEnterix Announces Submission of General Surgery Expansion in the US

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has submitted an indications filing to the FDA to expand General Surgery usage of the Senhance Surgical System. “This submission is an important milestone for the continued application of Senhance in the highest volume and value procedures,” said Anthony

Business Wire | August 4, 2020

Read More 'TRXC' Stories Here

TRXC Price Returns

1-mo 3.63%
3-mo -26.29%
6-mo -14.95%
1-year -87.86%
3-year -99.06%
5-year -98.89%
YTD -75.51%
2019 -95.00%
2018 17.10%
2017 48.46%
2016 -47.58%
2015 -14.78%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8899 seconds.